News & Updates

Show Multimedia Only

Bulevirtide works well against chronic hepatitis D, HIV/HBV/HDV coinfection

21 Mar 2024 by

Patients with hepatitis delta virus (HDV) show increased virologic and biochemical responses with longer bulevirtide (BLV) treatment for over 96 weeks, with no new safety concerns, as shown in a study presented at CROI 2024.

Bulevirtide works well against chronic hepatitis D, HIV/HBV/HDV coinfection

21 Mar 2024

The Pharmacist Healthcare Leadership Forum 2024 prepares pharmacists for leadership roles

21 Mar 2024

The first-ever Pharmacist Healthcare Leadership Forum, organized by the Hospital and Clinical Pharmacy Chapter of the Malaysian Pharmacists Society and supported by MIMS as the media partner, was a resounding success.

The Pharmacist Healthcare Leadership Forum 2024 prepares pharmacists for leadership roles

21 Mar 2024

Can’t stress enough: Healthy living prevents T2D

21 Mar 2024

Adherence to a healthy lifestyle, particularly a well-balanced diet, protects against the development of type 2 diabetes (T2D), with differences across ethnicities, suggests a US study.

Can’t stress enough: Healthy living prevents T2D

21 Mar 2024

Liver cancer focus of this year’s World Cancer Day awareness event at UKM

21 Mar 2024 by

The Academy of Medicine Malaysia (AMM) and the Gastroenterology and Hepatology Unit, Department of Medicine and Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), recently organized a Liver Cancer Awareness Day in conjunction with World Cancer Day 2024. The public event was aimed at bringing the university closer to the community.

Liver cancer focus of this year’s World Cancer Day awareness event at UKM

21 Mar 2024

MHAS highlights age-related muscle loss in rapidly aging Malaysia, urges for prevention

21 Mar 2024 by

Malaysia is facing a significant demographic shift, with forecasts indicating that by the year 2040, around 15 percent of the population will be aged 65 and above. This growing segment of the population faces a critical challenge—age-related muscle loss, which is detrimental to the pursuit of healthy aging. Presently, one in three adults over the age of 60 suffers from reduced muscle mass, adversely affecting their strength and overall health.

MHAS highlights age-related muscle loss in rapidly aging Malaysia, urges for prevention

21 Mar 2024

New biologic treatment for MS promises to improve patients’ QOL

21 Mar 2024 by

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, is now available in Malaysia. The molecule is indicated for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). It targets CD20 marker on B lymphocytes and is an immunosuppressive drug.

New biologic treatment for MS promises to improve patients’ QOL

21 Mar 2024

Alcohol use disorder linked to suicide mortality in men, women

21 Mar 2024

People with alcohol use disorder (AUD) have greater odds of dying by suicide, and this association is consistent in men and women, according to the results of a systematic review and meta-analysis.

Alcohol use disorder linked to suicide mortality in men, women

21 Mar 2024

Lung cancer in HK in 2002–2021: Increasing burden, survival improves but remains low

21 Mar 2024 by

The University of Hong Kong’s (HKU) comprehensive analysis of lung cancer trends in Hong Kong between 2002 and 2021 reports an increase in crude incidence, a decline in age-standardized incidence, and an increase in survival rates, which, however, remained <40 percent at 5 years.

Lung cancer in HK in 2002–2021: Increasing burden, survival improves but remains low

21 Mar 2024

Older patients with focal structural epilepsy at risk of postictal dysphagia

20 Mar 2024

Older patients with focal structural epilepsy are more likely to experience swallowing problems after seizures, according to a study.

Older patients with focal structural epilepsy at risk of postictal dysphagia

20 Mar 2024

Vitamin B6 best bet against antipsychotic-induced akathisia

20 Mar 2024 by

Mirtazapine, biperiden, and vitamin B6 are all beneficial in the treatment of antipsychotic-induced akathisia (AIA), with vitamin B6 having the best efficacy and tolerability profile, according to the results of a meta-analysis.

Vitamin B6 best bet against antipsychotic-induced akathisia

20 Mar 2024

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Bulevirtide works well against chronic hepatitis D, HIV/HBV/HDV coinfection

Bulevirtide works well against chronic hepatitis D, HIV/HBV/HDV coinfection

The Pharmacist Healthcare Leadership Forum 2024 prepares pharmacists for leadership roles

The Pharmacist Healthcare Leadership Forum 2024 prepares pharmacists for leadership roles

Can’t stress enough: Healthy living prevents T2D

Can’t stress enough: Healthy living prevents T2D

Liver cancer focus of this year’s World Cancer Day awareness event at UKM

Liver cancer focus of this year’s World Cancer Day awareness event at UKM

MHAS highlights age-related muscle loss in rapidly aging Malaysia, urges for prevention

MHAS highlights age-related muscle loss in rapidly aging Malaysia, urges for prevention

New biologic treatment for MS promises to improve patients’ QOL

New biologic treatment for MS promises to improve patients’ QOL

Alcohol use disorder linked to suicide mortality in men, women

Alcohol use disorder linked to suicide mortality in men, women

Lung cancer in HK in 2002–2021: Increasing burden, survival improves but remains low

Lung cancer in HK in 2002–2021: Increasing burden, survival improves but remains low

Older patients with focal structural epilepsy at risk of postictal dysphagia

Older patients with focal structural epilepsy at risk of postictal dysphagia

Vitamin B6 best bet against antipsychotic-induced akathisia

Vitamin B6 best bet against antipsychotic-induced akathisia